Back to Search
Start Over
Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation: does mTOR inhibitors association augment toxicity?
- Source :
-
European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2014 May; Vol. 26 (5), pp. 577-8. - Publication Year :
- 2014
- Subjects :
- Carcinoma, Hepatocellular enzymology
Carcinoma, Hepatocellular pathology
Drug Interactions
Everolimus
Humans
Liver Neoplasms enzymology
Liver Neoplasms pathology
Male
Middle Aged
Molecular Targeted Therapy
Niacinamide adverse effects
Sirolimus adverse effects
Sorafenib
Treatment Outcome
Antineoplastic Agents adverse effects
Carcinoma, Hepatocellular therapy
Immunosuppressive Agents adverse effects
Liver Neoplasms therapy
Liver Transplantation
Neoplasm Recurrence, Local
Niacinamide analogs & derivatives
Phenylurea Compounds adverse effects
Protein Kinase Inhibitors adverse effects
Sirolimus analogs & derivatives
TOR Serine-Threonine Kinases antagonists & inhibitors
Subjects
Details
- Language :
- English
- ISSN :
- 1473-5687
- Volume :
- 26
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- European journal of gastroenterology & hepatology
- Publication Type :
- Editorial & Opinion
- Accession number :
- 24694739
- Full Text :
- https://doi.org/10.1097/MEG.0000000000000073